D to animals immunized with the outer membranes were observed independent

D to animals immunized with the outer membranes were observed independent of the MHC class II haplotypes of vaccinates. This is consistent with the presence of multiple immunogenic epitopes in AM779 that can be presented via the diverse MHC class II molecules represented within the immunized population. These results suggest that for AM779 relative abundance in the immunogen may be deterministic for T cell responses rather than intrinsic epitope structure being responsible for sub-dominance relative to major components such as Msp2 and Msp3. The anamnestic response upon challenge with A. marginale indicates that while of low abundance in the K162 manufacturer bacterial outer membrane, there is sufficient antigen to stimulate memory B lymphocytes, cells which due to high affinity immunoglobulin receptors induced by prior immunization have a much lower antigen requirement for reactivation [30]. Interestingly, the AM779 specific recall response was detected earlier in the AM779 vaccinates than in the outer membrane vaccinates, suggesting that there may have been differences in the vaccine induced priming between the two groups. This is consistent with the more uniform AM779 specific T cell response in the AM779 vaccinates which may provide more robust help upon re-exposure to the antigen. In addition, the anamnestic response to infectious challenge in the animals immunized with AM779 supports that the recombinant immunogen faithfully represents native epitope structure. Importantly, the challenge was via feeding of infected ticks and thus both the infectious dose and bacterial structure were representative of natural transmission. AM779 responses, whether induced by immunization with recombinant AM779, outer membranes, or surface complexes, did not associate with protective immunity. Thus, we reject the fourth tested hypothesis. While lack of protection in experimental vaccine trials is always a disappointment, this reporting is as important as for successful trials. The number of variables involved in immunization (adjuvant, antigen dose, route of delivery, numberof boosters, vaccine interval, etc.) make it difficult to conclude that a specific antigen, in this case AM779, should no longer be considered a viable vaccine candidate. Nonetheless, we can conclude that even with AM779 specific titers that significantly exceed those induced in outer membrane or surface complex immunized animals, AM779 by itself is not protective. Whether a single sub-dominant antigen can protect against infection with A. marginale or Hexokinase II Inhibitor II, 3-BP site related pathogens is unresolved. AM779 was identified as being a component of three protective immunogens: outer membranes, surface complexes, and the live A. marginale ss. centrale vaccine strain [4]. However all three of these protective immunogens are themselves complex. The outer membrane is composed of 21 identified proteins that induce IgG2 in vaccinates while the surface complexes contain 11 proteins [4],[7],[19]. The live vaccine strain, of course, has the full complement of outer membrane proteins, estimated from combined bioinformatics and proteomic analyses to exceed 60 [18],[19],[22],[31]. Consequently, in conceptualizing vaccines for A. marginale and related pathogens, it may be helpful to borrow definitions from molecular pathogenesis. In this view, subdominant antigens such as AM779 may be “required” but “not sufficient” to induce protective immunity. Inducing uniform protection among vaccinates using complex immunogens such as th.D to animals immunized with the outer membranes were observed independent of the MHC class II haplotypes of vaccinates. This is consistent with the presence of multiple immunogenic epitopes in AM779 that can be presented via the diverse MHC class II molecules represented within the immunized population. These results suggest that for AM779 relative abundance in the immunogen may be deterministic for T cell responses rather than intrinsic epitope structure being responsible for sub-dominance relative to major components such as Msp2 and Msp3. The anamnestic response upon challenge with A. marginale indicates that while of low abundance in the bacterial outer membrane, there is sufficient antigen to stimulate memory B lymphocytes, cells which due to high affinity immunoglobulin receptors induced by prior immunization have a much lower antigen requirement for reactivation [30]. Interestingly, the AM779 specific recall response was detected earlier in the AM779 vaccinates than in the outer membrane vaccinates, suggesting that there may have been differences in the vaccine induced priming between the two groups. This is consistent with the more uniform AM779 specific T cell response in the AM779 vaccinates which may provide more robust help upon re-exposure to the antigen. In addition, the anamnestic response to infectious challenge in the animals immunized with AM779 supports that the recombinant immunogen faithfully represents native epitope structure. Importantly, the challenge was via feeding of infected ticks and thus both the infectious dose and bacterial structure were representative of natural transmission. AM779 responses, whether induced by immunization with recombinant AM779, outer membranes, or surface complexes, did not associate with protective immunity. Thus, we reject the fourth tested hypothesis. While lack of protection in experimental vaccine trials is always a disappointment, this reporting is as important as for successful trials. The number of variables involved in immunization (adjuvant, antigen dose, route of delivery, numberof boosters, vaccine interval, etc.) make it difficult to conclude that a specific antigen, in this case AM779, should no longer be considered a viable vaccine candidate. Nonetheless, we can conclude that even with AM779 specific titers that significantly exceed those induced in outer membrane or surface complex immunized animals, AM779 by itself is not protective. Whether a single sub-dominant antigen can protect against infection with A. marginale or related pathogens is unresolved. AM779 was identified as being a component of three protective immunogens: outer membranes, surface complexes, and the live A. marginale ss. centrale vaccine strain [4]. However all three of these protective immunogens are themselves complex. The outer membrane is composed of 21 identified proteins that induce IgG2 in vaccinates while the surface complexes contain 11 proteins [4],[7],[19]. The live vaccine strain, of course, has the full complement of outer membrane proteins, estimated from combined bioinformatics and proteomic analyses to exceed 60 [18],[19],[22],[31]. Consequently, in conceptualizing vaccines for A. marginale and related pathogens, it may be helpful to borrow definitions from molecular pathogenesis. In this view, subdominant antigens such as AM779 may be “required” but “not sufficient” to induce protective immunity. Inducing uniform protection among vaccinates using complex immunogens such as th.